Why the study?
Does transcatheter closure using the Amplatzer Septal Occluder under transesophageal echocardiography alone without fluoroscopy achieve safe closure in pediatric patients with atrial septal defects?
Does transcatheter closure using the Amplatzer Septal Occluder under transesophageal echocardiography alone without fluoroscopy achieve safe closure in pediatric patients with atrial septal defects?
Transcatheter closure of centrally located atrial septal defects using the Amplatzer Septal Occluder can be safely performed under transesophageal echocardiography guidance alone without fluoroscopy in selected pediatric patients.
Answers are grounded in this paper and cite their sources.
Supports feasibility of fluoroscopy-free pediatric ASD closure; hypothesis-generating and should not yet change practice.
BACKGROUND: Transcatheter closure of atrial septal defects is performed under fluoroscopy, but echocardiography has gained an important role in the procedure. With the new Amplatzer Septal Occluder a device has become available which is easy to implant with minimal fluoroscopy time. We developed an interventional procedure with this device under transesophageal echocardiography alone without fluoroscopy. METHODS AND RESULTS: Four patients (3 to 16 years of age, bodyweight 14 to 60 kg) with atrial septal defects centrally located in the oval fossa were elected for transcatheter closure. After sedation with midazolam and propofol a diagnostic and interventional catheterization was performed in all cases without fluoroscopy. Oxymetric shunt was Qp: Qs = 1.7 (1.5 to 2.1). Under transesophageal echocardiography, the defects were sized over the wire with a balloon catheter. Mean balloon stretched diameter was 10 mm (7 to 14 mm). Under transesophageal echocardiography an Amplatzer Septal Occluder was placed into the defect. In two patients this was achieved with a 5 MHz monoplane pediatric transducer, in two patients a 10mm 5 MHz multiplane probe was used. Complete closure was achieved in all patients and no complications were encountered. CONCLUSION: We conclude that in selected cases with an atrial septal defect located in the oval fossa and clear-cut echocardiographic findings, an Amplatzer Septal Occluder can be safely deployed under echocardiographic guidance alone.
No takes yet. Share an insight, caveat, or question.
Ewert et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: